A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 10, 2007, Pages 837-851

  Geier, David A ^a   Geier, Mark R ^b,c  

^a Institute of Chronic Illnesses Inc   (United States)

^b Genetic Centers of America   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GLUTATHIONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MERCURY; THIOMERSAL;

ADOLESCENT; ARTICLE; AUTISM; BIOCHEMISTRY; BRAIN DISEASE; CASE STUDY; CHELATION; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOSE RESPONSE; EXCRETION; EXPOSURE; FEMALE; FETUS DEVELOPMENT; HUMAN; MALE; MERCURIALISM; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RETT SYNDROME; SEX HORMONE DETERMINATION;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MERCURY POISONING; NEUROTOXICITY SYNDROMES; THIMEROSAL;

EID: 34247349622     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701212141     Document Type: Article

References (88)

1. Amin-Zaki, L., Majeed, M. A., Greenwood M. R., Elhassani, S. B., Clarkson T. W., and Doherty, R. A. 1981. Methylmercury poisoning in the Iraqi suckling infant: a longitudinal study over five years. J. Appl. Toxicol. 1:210-214.
2. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I. Montgomery, M., Rutter, M., and Lantos, P. 1998. A clinicopathological study of autism. Brain 121:889-905.
3. Baskin, D. S., Ngo, H., and Didenko, V. V. 2003. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol. Sci. 74:361-368.
4. Bernard, S., Enayati, A., Redwood, L., Roger, H., and Binstock, T. 2001. Autism: a novel form of mercury poisoning. Med. Hypoth. 56:462-471.
5. Bernard, S., Enayati, A., Roger, H., Binstock, T., and Redwood, L. 2002. The role of mercury in the pathogenesis of autism. Mol. Psychiat. 7(suppl. 2):S42-S43.
6. Blair, A. M. J. N., Clark, B., Clarke, A. J., and Wood, P. 1975. Tissue concentrations of mercury after chronic dosing of squirrel monkeys with Thiomersal. Toxicology 3:171-176.
7. Blaxill, M. F., Redwood, L., and Bernard, S. 2004. Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med. Hypoth. 62:788-794.
8. Boris, M., Goldblatt, A., Galanko, J., and James, S. J. 2004. Association of 5, 10-methylenetetrathydrofolate reductase (MTHFR) gene polymorphisms with autistic spectrum disorders. J. Am. Phys. Surg. 9:106-108.
9. Bradstreet, J., Geier, D. A., Kartzinel, J. J., Adams, J. B., and Geier, M. R. 2003. A case-control study of mercury burden in children with autistic spectrum disorders. J. Am. Phys. Surg. 8:76-79.
10. Brown, L. E., and Yel, L. 2003. Thimerosal induces programmed cell death of neuronal cells via changes in the mitochondrial environment. UCI Undergrad. Res. J. 6:7-14.
11. Brunner, M., Albertini, S., and Wurgler, F. E. 1991. Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay. Mutagenesis 6:65-70.
12. Burbacher, T. M., Shen, D. D., Liberato, N., Grant, K. S., Cernichiari, E., and Clarkson, T. W. 2005. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing Thimerosal. Environ. Health Perspect. 113:1015-1021.
13. Buyske, S., Williams, T. A., Mars, A. E., Stenroos, E. S., Ming, S. X., Wang, R., Sreenath, M., Factura, M. F., Reddy, C., Lambert, G. H., and Johnson, W. G. 2006. BMC Genet. 7:8.
14. California Department of Developmental Services. 2003. Autistic spectrum disorders - Changes in the California caseload - An update: 1999 Through 2002. Sacramento: State of California.
15. Charleston, J. S., Bolender, R. P., Mottet, N. K., Body, R. L., Vahter, M. E., and Burbacher, T. M. 1994. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methylmercury exposure. Toxicol. Appl. Pharmacol. 129:196-206.
16. Charleston, J. S., Body, R. L., Mottet, N. K., Vahter, M. E., and Burbacher, T. M. 1995. Autometallographic determination of inorganic mercury distribution in the cortex of Macaca fascicularis following long-term subclinical exposure to methylmercury and mercuric chloride. Toxicol. Appl. Pharmacol. 132:325-333.
17. Charleston, J. S., Body, R. L., Bolender, R. P., Mottet, N. K., Vahter, M. E., and Burbacher, T. M. 1996. Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. Neurotoxicology 17:127-138.
18. Chauhaun, A., and Chauhaun, V. 2006. Oxidative stress in autism. Pathophysiology 13: 171-181.
19. Chrysochoou, C., Rutishauser, C., Rauber-Luthy, C., Neuhaus, T., Boltshauser, E., and Superti-Furga, A. 2003. An 11 month-old boy with psychomotor regression and auto-aggressive behaviour. Eur. J. Pediatr. 162:559-561.
20. Clarkson, T. W., Nordberg, F. J., and Sager, P. R. 1985. Reproductive and developmental toxicity of metals. Scand. J. Work. Environ. Health 11:145-154.
21. Counter, S. A., Buchanan, L. H., Ortega, F., and Laurell, G. 2002. Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines. J. Toxicol. Environ. Health A 65:149-163.
22. Courchesne, E. 1991. Neuroanatomic imaging in autism. Pediatrics 87:781-790.
23. Courchesne, E., Townsend, J., and Saitoh, O. 1994. The brain in infantile autism: Posterior fossa structures are abnormal. Neurology 44:214-223.
24. Derban, L. K. 1974. Outbreak of food poisoning due to alkyl-mercury fungicide on southern Ghana state farm. Arch. Environ. Health 28:49-52.
25. Digar, A., Sensharma, G. C., and Samal, S. N. 1987. Lethality and teratogenicity of organic mercury (Thimerosal) on the chick embryo. J. Anat. Soc. India 36:153-159.
26. Engleson, G., and Herner, T. 1952. Alkyl mercury poisoning. Acta Pediatr. 41:289-294.
27. Environmental Working Group. 2004. Overloaded? New science, new insights about mercury and autism in susceptible children. Washington, DC: EWG Action Fund.
28. Fagan, D. G., Pritchard, J. S., Clarkson, T. W., and Greenwood, M. R. 1977. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch. Dis. Child. 52:962-964.
29. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. 2000. Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108(suppl. 1):13-21.
30. Gasset, A. R., Itoi, M., Ishii, Y., and Ramer, R. M. 1975. Teratogenicities of ophthalmic drugs. II. Teratogenicities and tissue accumulation of thimerosal. Arch. Ophthalmol. 93:52-55.
31. Geier, D. A., and Geier, M. R. 2003. An assessment of the impact of Thimerosal on neurodevelopmental disorders. Pediatr. Rehabil. 6:97-102.
32. Geier, D. A., and Geier, M. R., 2004a. A comparative evaluation of the effects of MMR immunization and mercury doses from Thimerosal-containing childhood vaccines on the population prevalence of autism. Med. Sci. Monit. 10:P133-P139.
33. Geier, D. A., and Geier, M. R. 2004b. Neurodevelopmental disorders following Thimerosal-containing childhood immunizations: A follow-up analysis. Int. J. Toxicol. 23:369-376.
34. Geier, D. A., and Geier, M. R. 2005. A two-phased population epidemiological study of the safety of Thimerosal-containing vaccines: A follow-up analysis. Med. Sci. Monit. 11:CR160-CR170.
35. Geier, D. A., and Geier M. R. 2006a. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines. Med. Sci. Monit. 12:CR231-CR239.
36. Geier, D. A., and Geier, M. R. 2006b. An evaluation of the effects of Thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. J. Toxicol. Environ. Health A 69:1481-1491.
37. Geier, D. A., and Geier, M. R. 2006c. Early downward trends in neurodevelopmental disorders following removal of Thimerosal-containing vaccines. J. Am. Phys. Surg. 11:8-13.
38. Geier, D. A., and Geier, M. R. 2006. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro. Endocrinol. Lett. 27: 401-413.
39. Geier, M. R., and Geier, D. A. 2003a. Neurodevelopmental disorders after Thimerosal-containing vaccines: A brief communication. Exp. Biol. Med. 228:660-664.
40. Geier, M. R., and Geier, D. A. 2003b. Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J. Am. Phys. Surg. 8:6-11.
41. Geier, M. R., and Geier, D. A. 2005. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med. Hypoth. 64:946-954.
42. Grandjean, P., Weihe, P., White, R. F., and Debes, F. 1998. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ. Res. 77:165-172.
43. Haley, B. E. 2005. Mercury toxicity: Genetic susceptibility and synergistic effects. Med. Ver. 2:535-542.
44. Harada, M. 1978. Congenital Minamata disease: Intrauterine methylmercury poisoning. Teratology 18:285-288.
45. Heinonen, O. P., Slone, D., and Shapiro, S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group.
46. Holmes, A. S., Blaxill, M. F., and Haley, B. E. 2003. Reduced levels of mercury in first baby haircuts of autistic children. Int. J. Toxicol. 22:277-285.
47. Hornig, M., Chian, D., and Lipkin, W. I. 2004. Neurotoxic effects of postnatal Thimerosal are mouse strain dependent. Mol. Psychiat. 9:833-845.
48. Humphrey, M. L., Cole, M. P., Pendergrass, J. C., and Kiningham, K. K. 2005. Mitochondrial mediated Thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology 26:407-416.
49. Itoi, M., Ishii, Y., and Kaneko, N. 1972. Teratogenicities of antiviral ophthalmics on experimental animals. Jpn. J. Clin. Ophthal. 26:631-640.
50. James, S. J., Cutler, P., Myelnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., and Neubrander, J. A. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:1611-1617.
51. James, S. J., Slikker, W., Melnyk, S., New, E., Pogribna, M., and Jernigan, S. 2005. Thimerosal neurotoxicity is associated with glutathione depletion: Protection with glutathione precursors. Neurotoxicology 26:1-8.
52. Kemper, T. L., and Bauman, M. L. 1993. The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11:175-187.
53. Leonard, A., Jacquet, P., and Lauwerys, R. R. 1983. Mutagenicity and terato-genicity of mercury compounds. Mutat. Res. 114:1-18.
54. Matheson, D. S., Clarkson, T. W., and Gelfand, E. W. 1980. Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin. J. Pediatr. 97:153-155.
55. McGinnis, W. R. 2004. Oxidative stress in autism. Altern. Ther. Health Med. 10:22-36.
56. Miles, J. H., Takahashi, T. N., Bagby, S., Sahota, P. K., Vaslow, D. F., Wang, C. H., Hillman, R. E., and Farmer, J. E. 2005. Essential versus complex autism: Definition of fundamental prognostic subtypes. Am. J. Med. Genet. A 135:171-180.
57. Mutkus, L., Aschner, J. L., Syversen, T., Shanker, G., Sonnewald, U., and Aschner, M. 2005. In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative Thimerosal. Biol. Trace Elem. Res. 105:71-86.
58. Mutter, J., Naumann, J., Schneider, R., Walach, H., and Haley, B. 2005. Mercury and autism: Accelerating evidence? Neuro. Endocrinol. Lett. 26:439-446.
59. Nataf, R., Skorupka, C., Amet, L., Lam, A., Springbett, A., and Lathe, R. 2006. Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity. Toxicol. Appl. Pharmacol. 214: 99-108.
60. Palmer, J. F., Blanchard, S., Stein, S., Mandell, D., and Miller, C. 2006. Environmental mercury release, special education rates, and autism disorder: An ecological study of Texas. Health Place 12:203-209.
61. Parran, D. K., Barker, A., and Ehrich, M. 2005. Effects of Thimerosal on NGF signal transduction and cell death in neuroblastoma cells. Toxicol. Sci. 86:132-140.
62. Parry, J. M. 1993. An evaluation of the use of in vitro tubulin polymerisation, fungal and wheat assays to detect the activity of potential chemical aneugens. Mutat. Res. 287:23-28.
63. Pelclova, D., Lukas, E., Urban, P., Preiss, J., Rysava, R., Lebenhart, P., Okrouhhlik, B., Fenclova, Z., Lebedova, J., Stejskalova, A., and Ridzon, P. 2002. Mercury intoxication from skin ointment containing mercuric ammonium chloride. Int. Arch. Occup. Environ. 75(suppl.):S54-S59.
64. Reader, M. J., and Lines, C. B. 1983. Decomposition of Thimerosal in aqueous solution and its determination by high-performance liquid chromatography. J. Pharm. Sci. 72:1406-1409.
65. Redwood, L., Bernard, S., and Brown, D. 2001. Predicted mercury concentrations in hair from infant immunizations: Cause for concern. Neurotoxicology 22:691-697.
66. Ritvo, E. R., Freeman, B. J., Scheibel, A. B., Duong, T., Robinson, H., Guthrie, D., and Ritvo, A. 1986. Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSAC Autopsy Research Report. Am. J. Psychiatry 143:862-866.
67. Rohyans, J., Walson, P. D., Wood, G. A., and MacDonald, W. A. 1984. Mercury toxicity following merthiolate ear irrigations. J. Pediatr. 104:311-313.
68. Sager, P. R., Aschner, M., and Rodier, P. M. 1984. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Brain Res. 314:1-11.
69. Sakamoto, M., Kakita, A., Wakabayashi, K., Takahashi, H., Nakano, A., and Akagi, H. 2002. Evaluation of changes in methylmercury accumulation in the developing rat brain and its effects: A study with consecutive and moderate dose exposure throughout gestation and lactation periods. Brain Res. 949:51-59.
70. Serajee, F. J., Nabi, R., Zhong, H., and Hug M. 2004. Polymorphisms in xenobiotic metabolism genes and autism. J. Child. Neurol. 19:413-417.
71. Slikker, W. 2000. Developmental neurotoxicology of therapeutics: Survey of novel recent findings. Neurotoxicology 21:250.
72. Sorensen, F. W., Larsen, J. O., Eide, R., and Schionning, J. D. 2000. Neuron loss in cerebellar cortex of rats exposed to mercury vapor: A stereological study. Acta Neuropathol. 100:95-100.
73. Stajich, G. V., Lopez, G. P., Harry, S. W., and Sexson, W. R. 2000. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J. Pediatr. 136:679-681.
74. Suzuki, T., Takemoto, T. L., Kashiwazaki, H., and Miyama, T. 1973. Metabolic fate of ethylmercury salts in man and animals. In: Mercury, mercurials, mercaptans, eds. M. W. Miller, and T. W. Clarkson, pp. 209-240. Springfield, IL: Charles C. Thomas.
75. Tryphonas, L., and Nielsen, N. O. 1973. Pathology of chronic alkymercurial poisoning in swine. Am. J. Vet. Res. 34:379-392.
76. 203Hg labeled mercury compounds in adult and pregnant mice determined by whole-body autoradiography. Radioisotopes 16:440-448.
77. Vahter, M., Mottet, N. K., Friberg, L., Lind, B., Shen, D. D., and Burbacher, T. 1994. Speciation of mercury in the primate blood and brain following long-term exposure to methylmercury. Toxicol. Appl. Pharmacol. 124:221-229.
78. Vahter, M. E., Mottet, N. K., Friberg, L. T., Lind, S. B., Charleston, J. S., and Burbacher, T. M. 1995. Demethylation of methylmercury in different brain sites of Macaca fascicularis monkeys during longterm subclinical methylmercury exposure. Toxicol. Appl. Pharmacol. 134:273-284.
79. Vargas, D. L., Nascimbence, C., Krishnan, C., Zimmerman, A. W., and Pardo, C. A. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:67-81.
80. Verstraeten, T. 2004. Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. Pediatrics 113:932.
81. Verstraeten, T., Davis, R. L., DeStefano, F., Lieu, T. A., Rhodes, P. H., Black, S. B., Shinefield, H., Chen, R. T., and Vaccine Safety Datalink Team. 2003. Safety of Thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112:1039-1048.
82. Wallin, M., and Hartely-Asp, B. 1993. Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. Mutat. Res. 287:17-22.
83. Waly, M., Olteanu, H., Banerjee, R., Choi, S. W., Mason, J. B., Parker, B. S., Sukumar, S., Shim, S., Sharma, A., Benzeery, J. M., Power-Charnitsky, V. A., and Deth, R. C. 2004. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopmental toxins and Thimerosal. Mol. Psychiat. 9:358-370.
84. Warfvinge, K. 2000. Mercury distribution in the neonatal and adult cerebellum after mercury vapor exposure of pregnant squirrel monkeys. Environ. Res. 83:93-101.
85. Werner, E., and Dawson, G. 2005. Validation of the phenomenon of autistic regression using home videotapes. Arch. Gen. Psychiat. 62:889-895.
86. Windham, G. C., Zhang, L, Gunier, R., Croen, L. A., and Grether, J. K. 2006. Autism spectrum disorders in related to distribution of hazardous air pollutants in the San Francisco Bay area. Environ. Health Persp. 114: 1438-1444.
87. Yel, L., Brown, L. E., Su, K., Gollapudi, S., and Gupta, S. 2005. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int. J. Mol. Med. 16:971-977.
88. Zhang, J. 1984. Clinical observations in ethyl mercury chloride poisoning. Am. J. Ind. Med. 5:251-258.